What is the main purpose of this 8-K filing?

The main purpose of this 8-K filing is to furnish the press release announcing Boston Scientific's financial results for the first quarter ended March 31, 2020. It serves as a notification and provides access to the detailed earnings information.

Where can I find the actual Q1 2020 financial results?

The actual Q1 2020 financial results are located in the press release issued by Boston Scientific Corporation on April 29, 2020, which is included as Exhibit 99.1 to this 8-K filing.

Are the results mentioned in the press release considered officially 'filed' with the SEC?

The information furnished under Item 2.02, including the press release, is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934. This means it is not subject to the liabilities of that section, though it is still publicly disclosed.

What kind of information should I expect to find in the press release?

You should expect to find key financial metrics such as revenue, earnings per share (EPS), net income, and potentially commentary from management on the company's performance, strategic updates, and outlook for the future. Given the filing date, information related to the impact of the COVID-19 pandemic on their operations and guidance may also be present.

BSX 8-K: Earnings & Results

Summary

Boston Scientific Corporation (BSX) filed an 8-K on April 29, 2020, primarily to furnish a press release detailing their first-quarter financial results for the period ended March 31, 2020. The filing itself doesn't contain the detailed financial data but points investors to an accompanying press release (Exhibit 99.1) for this information. Therefore, investors should review the press release for specific operational and financial performance metrics, including revenue, profitability, and any forward-looking guidance provided by the company for the upcoming periods.

Key Highlights

1The 8-K filing's main purpose is to announce and provide access to Boston Scientific's Q1 2020 earnings press release.
2The press release (Exhibit 99.1) contains the detailed financial results for the first quarter ended March 31, 2020.
3The filing does not contain the detailed financial figures directly but directs investors to the furnished press release.
4Information furnished under Item 2.02 is not considered 'filed' for certain SEC regulations, limiting liability under specific sections of the Exchange Act.
5Investors need to consult the press release to understand the company's performance, financial condition, and any management commentary for Q1 2020.
6The filing includes the standard Cover Page Interactive Data File (XBRL) for enhanced data accessibility.

BOSTON SCIENTIFIC CORP 8-K Report, Financial Results (Apr 29, 2020)

Summary

Key Highlights

Frequently Asked Questions